Form 4: TransDigm GC Acquires 17,100 Stock Options

TransDigm Group's General Counsel, Armani Vadiee, acquired 17,100 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026.

Summary

• Armani Vadiee, TransDigm Group's General Counsel, Chief Compliance Officer, and Secretary, acquired 17,100 stock options.
• The options have an exercise price of $1,291.97 per share.
• The transaction date for the acquisition was November 4, 2025.
• These options become exercisable at 20% per year over five years, commencing September 30, 2026.
• Exercisability is contingent upon the achievement of annual operating performance targets in each respective year.
• The options expire on November 4, 2035.
• Following this transaction, Armani Vadiee beneficially owns 17,100 derivative securities directly.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a key executive, tied to performance targets, is generally viewed positively as it aligns management incentives with shareholder interests. It's a routine compensation event, not indicative of major operational shifts, hence a moderately positive score.

Positives

• Acquisition of stock options by a key executive (GC, CCO, Secretary) aligns management's interests with shareholder value.
• The vesting schedule tied to annual operating performance targets incentivizes long-term company success and performance.

Future Outlook

The vesting of these stock options is tied to future annual operating performance targets, indicating a forward-looking incentive structure for the executive.

Industry Context

This filing is a routine disclosure of executive compensation in the form of stock options, common practice across various industries, including aerospace and defense, where TransDigm operates. Such grants are designed to align executive incentives with long-term company performance and shareholder returns.

Comparison to Industry Standards

• Granting performance-based stock options to key executives like the General Counsel is a standard practice in publicly traded companies, aligning executive interests with long-term shareholder value, similar to practices at peers such as Raytheon Technologies (RTX) or Lockheed Martin (LMT).
• The five-year vesting schedule with annual performance targets is a common structure for executive equity awards, comparable to incentive plans seen in other large industrial and aerospace companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of performance-based stock options to a key executive aligns management's financial incentives with the company's long-term performance, potentially benefiting shareholders through increased value creation.
• Employees: While not directly impacting all employees, the executive's incentive structure can influence overall company strategy and performance, which indirectly affects all employees.

Next Steps

• Armani Vadiee will be able to exercise 20% of the options annually starting September 30, 2026, subject to performance targets.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a key executive as part of their compensation package. While it aligns management incentives with shareholder interests, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard disclosure that reinforces existing compensation practices.

Keywords

TransDigm Group, TDG, Stock Options, Insider Trading, Executive Compensation, Armani Vadiee, SEC Form 4, Derivative Securities, Performance Targets